AAPL   325.12 (+0.55%)
MSFT   185.36 (+0.24%)
FB   230.16 (-1.10%)
GOOGL   1,439.25 (-0.21%)
AMZN   2,478.40 (+0.24%)
NVDA   350.78 (-0.63%)
CGC   16.57 (+2.66%)
BABA   218.61 (+2.00%)
MU   48.92 (+4.49%)
GE   7.36 (+4.40%)
TSLA   882.96 (+0.16%)
AMD   52.73 (-1.51%)
T   31.51 (+1.68%)
ACB   14.30 (-1.58%)
F   6.19 (+4.92%)
GILD   74.40 (+1.56%)
DIS   122.18 (+2.89%)
NFLX   421.97 (-1.25%)
BAC   25.99 (+4.63%)
BA   173.16 (+12.95%)
AAPL   325.12 (+0.55%)
MSFT   185.36 (+0.24%)
FB   230.16 (-1.10%)
GOOGL   1,439.25 (-0.21%)
AMZN   2,478.40 (+0.24%)
NVDA   350.78 (-0.63%)
CGC   16.57 (+2.66%)
BABA   218.61 (+2.00%)
MU   48.92 (+4.49%)
GE   7.36 (+4.40%)
TSLA   882.96 (+0.16%)
AMD   52.73 (-1.51%)
T   31.51 (+1.68%)
ACB   14.30 (-1.58%)
F   6.19 (+4.92%)
GILD   74.40 (+1.56%)
DIS   122.18 (+2.89%)
NFLX   421.97 (-1.25%)
BAC   25.99 (+4.63%)
BA   173.16 (+12.95%)
AAPL   325.12 (+0.55%)
MSFT   185.36 (+0.24%)
FB   230.16 (-1.10%)
GOOGL   1,439.25 (-0.21%)
AMZN   2,478.40 (+0.24%)
NVDA   350.78 (-0.63%)
CGC   16.57 (+2.66%)
BABA   218.61 (+2.00%)
MU   48.92 (+4.49%)
GE   7.36 (+4.40%)
TSLA   882.96 (+0.16%)
AMD   52.73 (-1.51%)
T   31.51 (+1.68%)
ACB   14.30 (-1.58%)
F   6.19 (+4.92%)
GILD   74.40 (+1.56%)
DIS   122.18 (+2.89%)
NFLX   421.97 (-1.25%)
BAC   25.99 (+4.63%)
BA   173.16 (+12.95%)
AAPL   325.12 (+0.55%)
MSFT   185.36 (+0.24%)
FB   230.16 (-1.10%)
GOOGL   1,439.25 (-0.21%)
AMZN   2,478.40 (+0.24%)
NVDA   350.78 (-0.63%)
CGC   16.57 (+2.66%)
BABA   218.61 (+2.00%)
MU   48.92 (+4.49%)
GE   7.36 (+4.40%)
TSLA   882.96 (+0.16%)
AMD   52.73 (-1.51%)
T   31.51 (+1.68%)
ACB   14.30 (-1.58%)
F   6.19 (+4.92%)
GILD   74.40 (+1.56%)
DIS   122.18 (+2.89%)
NFLX   421.97 (-1.25%)
BAC   25.99 (+4.63%)
BA   173.16 (+12.95%)
Log in

NASDAQ:VICLVical Stock Price, Forecast & News

Notice: This company has been marked as potentially delisted and may not be actively trading.
$1.12
-0.02 (-1.75 %)
(As of 06/3/2020 04:00 PM ET)
Add
Compare
Today's Range
$1.12
Now: $1.12
$1.15
50-Day Range
$0.68
MA: $1.24
$3.15
52-Week Range
$0.60
Now: $1.12
$1.47
Volume97,712 shs
Average Volume1.44 million shs
Market Capitalization$25.58 million
P/E RatioN/A
Dividend YieldN/A
Beta0.32
Vical Incorporated researches and develops biopharmaceutical products based on its DNA delivery technologies for the prevention and treatment of serious or life-threatening diseases. The company was founded in 1987 and is headquartered in San Diego, California.
Read More
Vical logo

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 2.8Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 1.3 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.81 out of 5 stars


Industry, Sector and Symbol

Industry Biological products, except diagnostic
Sub-IndustryBiotechnology
SectorMedical
Current SymbolNASDAQ:VICL
CUSIP92560210
Phone858-646-1100

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$1.62 million
Book Value$1.82 per share

Profitability

Net Income$-16,250,000.00
Net Margins-1,002.10%

Miscellaneous

Employees30
Market Cap$25.58 million
Next Earnings DateN/A
OptionableOptionable

Receive VICL News and Ratings via Email

Sign-up to receive the latest news and ratings for VICL and its competitors with MarketBeat's FREE daily newsletter.

Vical (NASDAQ:VICL) Frequently Asked Questions

How were Vical's earnings last quarter?

Vical Incorporated (NASDAQ:VICL) issued its quarterly earnings data on Tuesday, February, 19th. The biotechnology company reported ($0.17) EPS for the quarter, hitting the Zacks' consensus estimate of ($0.17). The biotechnology company had revenue of $0.12 million for the quarter, compared to analysts' expectations of $0.04 million. Vical had a negative return on equity of 29.46% and a negative net margin of 1,002.10%. View Vical's earnings history.

Has Vical been receiving favorable news coverage?

Media stories about VICL stock have trended somewhat positive this week, according to InfoTrie Sentiment. InfoTrie scores the sentiment of press coverage by monitoring more than six thousand blog and news sources. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Vical earned a news sentiment score of 0.9 on InfoTrie's scale. They also assigned news headlines about the biotechnology company a news buzz of 0.0 out of 10, indicating that recent press coverage is extremely unlikely to have an impact on the stock's share price in the near future. View the latest news aboutVical.

Who are some of Vical's key competitors?

What other stocks do shareholders of Vical own?

Who are Vical's key executives?

Vical's management team includes the following people:
  • Mr. Vijay B. Samant, CEO, Pres & Director (Age 66)
  • Dr. Lawrence Russell Smith, Sr. VP of Research (Age 58)
  • Mr. Anthony Alan Ramos, VP, CFO & Chief Accounting Officer (Age 52)
  • Dr. Mammen P. Mammen Jr., Former Sr. VP of Clinical Devel. (Age 55)

What is Vical's stock symbol?

Vical trades on the NASDAQ under the ticker symbol "VICL."

What is Vical's stock price today?

One share of VICL stock can currently be purchased for approximately $1.12.

How big of a company is Vical?

Vical has a market capitalization of $25.58 million and generates $1.62 million in revenue each year. The biotechnology company earns $-16,250,000.00 in net income (profit) each year or ($0.81) on an earnings per share basis. Vical employs 30 workers across the globe.

What is Vical's official website?

The official website for Vical is www.vical.com.

How can I contact Vical?

Vical's mailing address is 10390 PACIFIC CENTER COURT, SAN DIEGO CA, 92121. The biotechnology company can be reached via phone at 858-646-1100 or via email at [email protected]

This page was last updated on 6/3/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.